Search Results

Bio NC

Mycovia Pharmaceuticals, Inc. Announces AllianceRx Walgreens Pharmacy and Walgreens Community-based Specialty Pharmacies as Exclusive Distributor of VIVJOA®

Mycovia Pharmaceuticals, Inc., an emerging biopharmaceutical company, announced that patients now have exclusive access to VIVJOA® through AllianceRx Walgreens Pharmacy and Walgreens community-based specialty pharmacies, subsidiaries of Walgreens Boots Alliance, Inc.

March 26, 2024

·

5 min read

Press Releases

Walgreens Boots Alliance Reports Fiscal 2025 First Quarter Results

January 10, 2025

·

19 min read

Press Releases

Walgreens Boots Alliance Suspends Quarterly Dividend as Company Continues Disciplined Execution Against Strategic Priorities

January 30, 2025

·

3 min read

Business

Walgreens and Boehringer Ingelheim Are Partnering to Improve Diversity in Clinical Trials

Walgreens and Boehringer Ingelheim announced a strategic collaboration aimed at optimizing recruitment and making clinical trials more accessible, inclusive and equitable.

May 2, 2024

·

6 min read

Press Releases

Walgreens Launches Inaugural Patient Advisory Board to Advance Access and Representation in Clinical Research

December 13, 2024

·

3 min read

Press Releases

Walgreens Boots Alliance Adjusts Fiscal 2025 First Quarter Earnings Announcement to be Held on January 10

January 2, 2025

·

1 min read

Pictured: Boehringer Ingelheim's office in California

Drug Development

Boehringer, Walgreens Team Up for Obesity Trial as Weight-Loss Drug Race Heats Up

In an effort to improve diversity and accessibility in clinical trials, Boehringer Ingelheim is partnering with Walgreens to conduct a Phase III study in obesity and type 2 diabetes.

May 3, 2024

·

2 min read

·

Tristan Manalac

Deals

Cencora Announces Common Share Repurchase From Walgreens Boots Alliance and Raises Fiscal 2024 Guidance

Cencora, Inc. (NYSE: COR) today announced that it has agreed to repurchase shares of its common stock from Walgreens Boots Alliance Holdings LLC in the amount of approximately $400 million in a private transaction.

May 22, 2024

·

3 min read

Business

Walgreens Boots Alliance Reports Fiscal 2024 First Quarter Results

Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced financial results for the first quarter of fiscal 2024, which ended November 30, 2023.

January 4, 2024

·

37 min read

Deals

Walgreens Boots Alliance Declares Quarterly Dividend - January 4, 2024

Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced that its board of directors has declared a quarterly dividend of 25 cents per share, a reduction of 48 percent from the previous quarter.

January 4, 2024

·

4 min read